Israel's defense minister has said that the country has isolated a major coronavirus antibody at its main biological research laboratory, calling the move a "significant breakthrough" toward a possible treatment for the coronavirus pandemic.
'Monoclonal killing antibodies created for the Israel Institute for Biological Research (IIBR) may fix the infection causing coronavirus' Defense Minister Naftley Bennett said in an announcement.
The statement said Bennett visited IIBR on Monday where he was briefed on "significant success in finding an antidote for coronavirus".
It cited IIBR chief Shmuel Shapira as saying that the neutralizer equation was being licensed, after which a global maker would be looked to deliver it.
IIBR is spearheading Israel's efforts to develop a treatment and vaccine for coronavirus, including blood screening from COVID-19, a respiratory disease caused by the virus.
Antibodies in such samples - immune-system proteins that are the remains of successfully overcoming coronaviruses - are widely seen as the key to developing a potential cure.
The antibody isolated in IIBR is called monoclonal, meaning that it was derived from a recovered cell and thus has potential for a more potent value in a treatment yield.
The journal Science Direct reported in its May issue that antibodies to polyclonal, or coronavirus treatments originating from two or more cells have been developed.
Israel was one of the first countries to impose increasingly stringent restrictions on the movement to close its borders and prevent domestic coronavirus outbreaks. There were 16,246 cases and 235 deaths due to the disease.
0 Comments